The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

Q3 2025 Earnings Call Transcript November 3, 2025 Vertex, Inc. reports earnings inline with expectations. Reported EPS is ...

The stock, which is down more than 61% in 2025, sold off after reporting a Q3 EPS beat missing on revenue expectations.

One key figure, however, indicates otherwise as sales for Journavx were at $20 million for the period, coming up $3 million ...

Nigeria International and African Footballer of the Year, Ademola Lookman, has expressed his ongoing struggle to find his scoring form with Atalanta, despite recently netting his first goal of the ...

Vertex stock dipped late Monday despite better-than-expected third-quarter metrics and a slight sales guidance boost.

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. Learn more about VERX stock here.

Vertex (NASDAQ: VERX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table below ...

Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...

Discover Vertex’s Q3 2025 earnings: strong cloud growth, new CEO, $150M share buyback, and AI investments amid guidance cuts.

Chinese smartphone maker Oppo on Tuesday (October 28, 2025) unveiled its Find X9 series globally featuring two new smartphones, the Oppo Find X9 and Oppo Find X9 Pro, running ColorOS 16 based upon ...

AMSTERDAM, Oct 30 (Reuters) - Centrist D66 and the far-right Freedom Party (PVV) led by Geert Wilders were in a neck-and-neck race for the top spot in the Dutch election on Thursday. But with only 17% ...